Search research articles
Contact Us
Filters
Showing results (321-330 of 346) with videos related to
Page
of 35
Sort By:
Journal of Hematology & Oncology
|
February 23, 2021
Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML
Musa Yilmaz, Mansour Alfayez, Courtney D DiNardo, et al.
American Journal of Hematology
|
February 8, 2025
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies
Jayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, et al.
Cancer
|
May 6, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy
Jennifer Marvin-Peek, Courtney D DiNardo, Sanam Loghavi, et al.
Cancer
|
August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia
Jayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.
JCO Precision Oncology
|
December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia
Hannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
American Journal of Hematology
|
April 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Alex Bataller, Alexandre Bazinet, et al.
Blood Cancer Discovery
|
April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Leukemia
|
August 14, 2025
Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax
Jennifer Croden, Wei-Ying Jen, Jennifer Marvin-Peek, et al.
Cancer
|
March 19, 2021
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia
Elias Jabbour, Koji Sasaki, Nicholas J Short, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 346) with videos related to
Sort By:
Page
of 35
Journal of Hematology & Oncology
|
February 23, 2021
Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML
Musa Yilmaz, Mansour Alfayez, Courtney D DiNardo, et al.
American Journal of Hematology
|
February 8, 2025
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies
Jayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, et al.
Cancer
|
May 6, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy
Jennifer Marvin-Peek, Courtney D DiNardo, Sanam Loghavi, et al.
Cancer
|
August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia
Jayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.
JCO Precision Oncology
|
December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia
Hannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
American Journal of Hematology
|
April 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Alex Bataller, Alexandre Bazinet, et al.
Blood Cancer Discovery
|
April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Leukemia
|
August 14, 2025
Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax
Jennifer Croden, Wei-Ying Jen, Jennifer Marvin-Peek, et al.
Cancer
|
March 19, 2021
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia
Elias Jabbour, Koji Sasaki, Nicholas J Short, et al.
Page
of 35